Company profile ADVM
After 39 days of this quarter the interest is at 12.0. Based on that we can calculate that during remaining 52 days it will total up to 28.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 16 | 37 131.2% QoQ | 106 186.5% QoQ | 42 -60.4% QoQ |
| 2020 | 98 512.5% YoY 133.3% QoQ | 88 137.8% YoY -10.2% QoQ | 42 -60.4% YoY -52.3% QoQ | 31 -26.2% YoY -26.2% QoQ |
| 2021 | 54 -44.9% YoY 74.2% QoQ | 240 172.7% YoY 344.4% QoQ | 80 90.5% YoY -66.7% QoQ | 29 -6.5% YoY -63.8% QoQ |
| 2022 | 81 50.0% YoY 179.3% QoQ | 23 -90.4% YoY -71.6% QoQ | 33 -58.8% YoY 43.5% QoQ | 21 -27.6% YoY -36.4% QoQ |
| 2023 | 42 -48.1% YoY 100.0% QoQ | 32 39.1% YoY -23.8% QoQ | 26 -21.2% YoY -18.8% QoQ | 31 47.6% YoY 19.2% QoQ |
| 2024 | 12 -71.4% YoY -61.3% QoQ | - | - | - |
The average 5 years interest of Adverum Biotechnologies was 4.46 per week. The last year interest of Adverum Biotechnologies compared to the last 5 years has changed by -51.35%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -54.7%.
There is not enough data for ADVM-022 gene therapy to provide analysis
There is not enough data for ADVM-022 gene therapy to provide correlation calculation
There is not enough data for ADVM-022 gene therapy to provide analysis
There is not enough data for Wet AMD gene therapy to provide analysis
There is not enough data for Wet AMD gene therapy to provide correlation calculation
There is not enough data for Wet AMD gene therapy to provide analysis
There is not enough data for Diabetic macular edema gene therapy to provide analysis
There is not enough data for Diabetic macular edema gene therapy to provide correlation calculation
There is not enough data for Diabetic macular edema gene therapy to provide analysis
There is not enough data for Blue cone monochromacy gene therapy to provide analysis
There is not enough data for Blue cone monochromacy gene therapy to provide correlation calculation
There is not enough data for Blue cone monochromacy gene therapy to provide analysis
Google Trends for Adverum Biotechnologies clinical trials
Not enough data for reliable calculations!
There is not enough data for Adverum Biotechnologies clinical trials to provide analysis
There is not enough data for Adverum Biotechnologies clinical trials to provide correlation calculation
There is not enough data for Adverum Biotechnologies clinical trials to provide analysis
After 39 days of this quarter the interest is at 194.0. Based on that we can calculate that during remaining 52 days it will total up to 453.0. Gene therapy companies expected interest is significantly higher compared to previous quarter (+243.2%) and same quarter last year (+68.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 135 | 220 63.0% QoQ | 242 10.0% QoQ | 191 -21.1% QoQ |
| 2020 | 166 23.0% YoY -13.1% QoQ | 101 -54.1% YoY -39.2% QoQ | 162 -33.1% YoY 60.4% QoQ | 168 -12.0% YoY 3.7% QoQ |
| 2021 | 228 37.3% YoY 35.7% QoQ | 199 97.0% YoY -12.7% QoQ | 143 -11.7% YoY -28.1% QoQ | 114 -32.1% YoY -20.3% QoQ |
| 2022 | 112 -50.9% YoY -1.8% QoQ | 141 -29.1% YoY 25.9% QoQ | 206 44.1% YoY 46.1% QoQ | 216 89.5% YoY 4.9% QoQ |
| 2023 | 269 140.2% YoY 24.5% QoQ | 171 21.3% YoY -36.4% QoQ | 122 -40.8% YoY -28.7% QoQ | 132 -38.9% YoY 8.2% QoQ |
| 2024 | 194 -27.9% YoY 47.0% QoQ | - | - | - |
The average 5 years interest of Gene therapy companies was 13.92 per week. The last year interest of Gene therapy companies compared to the last 5 years has changed by 4.74%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -11.1%.
After 39 days of this quarter the interest is at 66.0. Based on that we can calculate that during remaining 52 days it will total up to 154.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 208 | 144 -30.8% QoQ | 86 -40.3% QoQ | 101 17.4% QoQ |
| 2020 | 80 -61.5% YoY -20.8% QoQ | 201 39.6% YoY 151.2% QoQ | 41 -52.3% YoY -79.6% QoQ | 158 56.4% YoY 285.4% QoQ |
| 2021 | 29 -63.8% YoY -81.6% QoQ | 91 -54.7% YoY 213.8% QoQ | 82 100.0% YoY -9.9% QoQ | 132 -16.5% YoY 61.0% QoQ |
| 2022 | 127 337.9% YoY -3.8% QoQ | 199 118.7% YoY 56.7% QoQ | 122 48.8% YoY -38.7% QoQ | 170 28.8% YoY 39.3% QoQ |
| 2023 | 234 84.3% YoY 37.6% QoQ | 341 71.4% YoY 45.7% QoQ | 259 112.3% YoY -24.0% QoQ | 231 35.9% YoY -10.8% QoQ |
| 2024 | 66 -71.8% YoY -71.4% QoQ | - | - | - |
The average 5 years interest of Gene therapy treatments was 11.89 per week. The last year interest of Gene therapy treatments compared to the last 5 years has changed by 65.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.0%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Adverum Biotechnologies stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 51 | 47 -7.8% QoQ | 169 259.6% QoQ | 149 -11.8% QoQ |
| 2020 | 91 78.4% YoY -38.9% QoQ | 16 -66.0% YoY -82.4% QoQ | 118 -30.2% YoY 637.5% QoQ | 35 -76.5% YoY -70.3% QoQ |
| 2021 | 92 1.1% YoY 162.9% QoQ | 244 1425.0% YoY 165.2% QoQ | 111 -5.9% YoY -54.5% QoQ | 57 62.9% YoY -48.6% QoQ |
| 2022 | 67 -27.2% YoY 17.5% QoQ | 74 -69.7% YoY 10.4% QoQ | 111 0.0% YoY 50.0% QoQ | 38 -33.3% YoY -65.8% QoQ |
| 2023 | 114 70.1% YoY 200.0% QoQ | 38 -48.6% YoY -66.7% QoQ | 80 -27.9% YoY 110.5% QoQ | 68 78.9% YoY -15.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Adverum Biotechnologies stock was 6.78 per week. The last year interest of Adverum Biotechnologies stock compared to the last 5 years has changed by -41.3%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -55.88%.
After 39 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 52 days it will total up to 58.0. Adverum Biotechnologies -stock -company expected interest is significantly higher compared to previous quarter (+inf%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 45 | 25 -44.4% QoQ | 74 196.0% QoQ | 94 27.0% QoQ |
| 2020 | 106 135.6% YoY 12.8% QoQ | 68 172.0% YoY -35.8% QoQ | 97 31.1% YoY 42.6% QoQ | 73 -22.3% YoY -24.7% QoQ |
| 2021 | 18 -83.0% YoY -75.3% QoQ | 249 266.2% YoY 1283.3% QoQ | 65 -33.0% YoY -73.9% QoQ | 94 28.8% YoY 44.6% QoQ |
| 2022 | 67 272.2% YoY -28.7% QoQ | 27 -89.2% YoY -59.7% QoQ | 52 -20.0% YoY 92.6% QoQ | 66 -29.8% YoY 26.9% QoQ |
| 2023 | 73 9.0% YoY 10.6% QoQ | 55 103.7% YoY -24.7% QoQ | 59 13.5% YoY 7.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2024 | 25 -65.8% YoY inf% QoQ | - | - | - |
The average 5 years interest of Adverum Biotechnologies -stock -company was 5.49 per week. The last year interest of Adverum Biotechnologies -stock -company compared to the last 5 years has changed by -38.43%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -36.82%.